A detailed history of Center Book Partners LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 305,599 shares of AGIO stock, worth $10.2 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
305,599
Previous 154,088 98.33%
Holding current value
$10.2 Million
Previous $6.85 Million 46.67%
% of portfolio
0.65%
Previous 0.44%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$32.86 - $61.64 $4.98 Million - $9.34 Million
151,511 Added 98.33%
305,599 $10 Million
Q3 2024

Nov 14, 2024

SELL
$41.19 - $49.72 $3.92 Million - $4.73 Million
-95,223 Reduced 38.19%
154,088 $6.85 Million
Q2 2024

Aug 12, 2024

BUY
$27.55 - $48.83 $6.87 Million - $12.2 Million
249,311 New
249,311 $10.8 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.82B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.